75 results
Page 2 of 4
6-K
EX-1.1
v4of63zpblmf7
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
jivut88yvo29kerd9
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
lojr9x9y7ixklj7
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
kmg1615 reffx08
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
2cf8eu
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
bmwc76zy9q81azg0ec
29 Jun 20
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
jjkb3z a2
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
xms0hdf2ajg3nk
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
c5xzb
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
6lvv8i8n mxmi83ih7o
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
aurdke3c23k5i2ctkvn1
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
aaa0krfavs lb4
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
94hrq xktthy2g7ao
26 Feb 20
Prospectus supplement for primary offering
8:23am